Edesa Biotech is trading 5.6% up at $5.53 today, staging a technical rebound following recent volatility and a thinly traded selloff.
- No fresh company-specific news, earnings, or FDA updates have been identified to account for the move.
- The price action is supported by a broadly risk-on market environment, with major U.S. indices all gaining more than 1%.
- Sentiment toward the growth and biotechnology sectors remains constructive, contributing to the stock's recovery.